Bill Text: CA SCR91 | 2011-2012 | Regular Session | Chaptered


Bill Title: Scleroderma Awareness Month.

Spectrum: Slight Partisan Bill (Democrat 73-40)

Status: (Passed) 2012-08-09 - Chaptered by Secretary of State. Res. Chapter 70, Statutes of 2012. [SCR91 Detail]

Download: California-2011-SCR91-Chaptered.html
BILL NUMBER: SCR 91	CHAPTERED
	BILL TEXT

	RESOLUTION CHAPTER  70
	FILED WITH SECRETARY OF STATE  AUGUST 9, 2012
	ADOPTED IN SENATE  AUGUST 6, 2012
	ADOPTED IN ASSEMBLY  JULY 5, 2012
	AMENDED IN ASSEMBLY  JULY 5, 2012

INTRODUCED BY   Senator Runner
   (Coauthors: Senators Alquist, Anderson, Berryhill, Blakeslee,
Calderon, Cannella, Corbett, Correa, De León, DeSaulnier, Dutton,
Emmerson, Evans, Fuller, Gaines, Hancock, Harman, Hernandez, Huff,
Kehoe, La Malfa, Leno, Lieu, Liu, Lowenthal, Negrete McLeod, Padilla,
Pavley, Price, Rubio, Simitian, Steinberg, Strickland, Vargas,
Walters, Wolk, Wright, Wyland, and Yee)
   (Coauthors: Assembly Members Knight, Smyth, Achadjian, Alejo,
Allen, Atkins, Beall, Bill Berryhill, Block, Blumenfield, Bonilla,
Bradford, Brownley, Buchanan, Butler, Charles Calderon, Campos,
Carter, Cedillo, Conway, Cook, Davis, Dickinson, Donnelly, Eng,
Feuer, Fong, Fuentes, Furutani, Beth Gaines, Galgiani, Garrick,
Gatto, Gordon, Gorell, Grove, Hagman, Halderman, Harkey, Hayashi,
Roger Hernández, Hill, Huber, Hueso, Jeffries, Jones, Lara, Logue,
Ma, Mansoor, Mendoza, Miller, Mitchell, Monning, Morrell, Nestande,
Nielsen, Olsen, Pan, Perea, John A. Pérez, V. Manuel Pérez,
Portantino, Silva, Skinner, Solorio, Swanson, Torres, Valadao,
Wagner, Wieckowski, Williams, and Yamada)

                        MAY 17, 2012

   Relative to Scleroderma Awareness Month.


	LEGISLATIVE COUNSEL'S DIGEST


   SCR 91, Runner. Scleroderma Awareness Month.
   This measure would proclaim June 2012 as Scleroderma Awareness
Month.



   WHEREAS, Scleroderma is a chronic, disabling autoimmune disease in
which the body's soft tissues contract and harden from an
overproduction of collagen; and
   WHEREAS, Scleroderma can affect many parts of the body including
skin, internal organs, and blood vessels; and
   WHEREAS, Scleroderma sufferers often experience damage to the
heart, lungs, kidneys, and the gastrointestinal tract; and
   WHEREAS, Scleroderma is associated with many other conditions
including pulmonary hypertension, gastroparesis, Raynaud's
phenomenon, Sjögren's syndrome, and lupus; and
   WHEREAS, Choctaw Native Americans, African Americans, and
Hispanics are disproportionately affected by scleroderma; and
   WHEREAS, Researchers have yet to identify the exact cause or
causes of scleroderma; and
   WHEREAS, An estimated 300,000 Americans suffer from scleroderma,
and 80 percent of those are women; and
   WHEREAS, The estimated total economic impact of scleroderma
treatment is estimated to be in excess of $1.5 billion annually; and
   WHEREAS, There is a significant need for further research focusing
on the epidemiology of scleroderma to increase understanding of the
causes of the disease and its treatment; and
   WHEREAS, The United States Congress has recognized the need to
raise awareness of the impact of scleroderma on public health and has
designated June as National Scleroderma Awareness Month; and
   WHEREAS, California should also designate a month as Scleroderma
Awareness Month to help educate the public about autoimmune diseases
and the need for increased research, funding, and effective
treatments for those diseases; and
   WHEREAS, The designation of such a month would recognize the
efforts of health care providers, patients, and scleroderma advocacy
organizations to raise awareness of scleroderma and of the need for
increased research on scleroderma; and
   WHEREAS, June 2012 would be an appropriate month to designate as
Scleroderma Awareness Month; now, therefore, be it
   Resolved by the Senate of the State of California, the Assembly
thereof concurring, That the Legislature proclaims the month of June
2012 as Scleroderma Awareness Month; and be it further
   Resolved, That the Secretary of the Senate transmit copies of the
resolution to the author for appropriate distribution.
                                                            
feedback